+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Asia-Pacific Arachidonic Acid Market - Growth, Trends And Forecasts (2019 - 2024)

  • ID: 4828314
  • Report
  • May 2019
  • Region: Asia Pacific
  • 80 Pages
  • Mordor Intelligence


  • BASF
  • Cargill. Inc
  • Cayman Chemicals
  • Guangdong Runke
  • Martek Bioscience
  • Royal DSM
Market Overview

Asia-Pacific Arachidonic acid market report is forecasted to reach USD 137.44 million by 2024 growing at a CAGR of 7.4% during the forecast period (2019 - 2024).
  • The major driver for the ARA market, is a high birth rate in countries, like India and China, has increased its application in infant formula products, sports nutrition, and dietary supplement products, and increased in fortification of products to meet the nutritional gap.
  • Also, the increase in the number of road accidents and the growing number of cases of muscle damage are expected to boost the demand. The increasing levels of childcare awareness, baby care products, and use of ARA as sports supplements serve as the primary growth drivers for ARA market.

Scope of the Report

The arachidonic acid market is distributed in a different segment on the application type, and by geography. In the application type, the arachidonic acid market is segmented into two major applications, namely, food & beverage and pharmaceutical. The food & beverage segment is further divided into infant formula and dietary supplements. Among food & beverage sub-segments, infant nutrition holds the dominant share of the market and being driven by regulatory support.

Key Market Trends

ARA In Infant Formula Products Driving The Market

The Infant Formula segment of the Asia-Pacific ARA market growing at a CAGR of 6.8%, during the forecast period. In the food application, infant nutrition covers the major share in the market. ARA, as a dietary supplement, is mainly used for sports nutrition products. The market segmentation, according to technology, further includes the solvent extraction technology and the solid phase extraction technology. The technology is segmented on the basis of efficiency of production and cost. The nutritional requirement among infants for neurological developments during the first two years means the demand for ARA remains constant. This fact is driving the infant formula segment of the ARA market.

China Is Major Producer Of Arachidonic Acid

China accounts for the largest share of the regional market, followed by India, Australia, and rest of Asia-Pacific. China is the world’s largest infant formula product market, which is the major factor for its large ARA consumption. China contributes to around 65% of the global infant formula market. Due to high quality and meet standards, there is a growing demand for imported infant formula in the country. The Japanese market is open to international players and has advanced regulatory principles, thereby driving the growth of the arachidonic acid market. Singapore, Malaysia, and Thailand have fairly developed economies, where consumers are aware of the availability of arachidonic acid products for improving their diets.

Competitive Landscape

Major Players: DSM, BASF, Cargill, Suntory, Martek Bioscience, Cabio Bioengineering, Guangdong Runke, Cayman Chemicals, A&Z Food additives Co. Ltd., Zhejiang Weiss (Wecan), and Kingdomway, among others. Advancement in biotechnology has given a good opportunity for the market. The microbiological source of production is giving a new opportunity for the market, as ARA is present in high concentration in microalgae. The production ARA from other sources than fungal is a big challenge for the market, due to its high raw material cost and wastage. The major competitors prefer investment in new product development and marketing strategy, due to volatility in commodity costs to maintain their position.

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • BASF
  • Cargill. Inc
  • Cayman Chemicals
  • Guangdong Runke
  • Martek Bioscience
  • Royal DSM

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
3.1 Market Overview
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5.1 By Technology
5.1.1 Solvent Extraction
5.1.2 Solid-Phase Extraction
5.2 By Application
5.2.1 Food and Beverage Infant Formula Dietary Supplements
5.2.2 Pharmaceuticals
5.3 Geography
5.3.1 Asia-Pacific India China Australia Japan Rest of Asia-Pacific
6.1 Market Share Analysis
6.2 Company Profiles
6.2.1 Cargill. Inc
6.2.2 Cabio Biotech (Wuhan)Co., Ltd
6.2.3 Cayman Chemicals
6.2.4 Martek Bioscience
6.2.5 Guangdong Runke
6.2.6 Royal DSM
6.2.7 A & Z Food Additives Co., Ltd
6.2.8 Zhejiang Weiss (Wecan)
6.2.9 BASF
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Cargill. Inc
  • Cabio Biotech (Wuhan)Co., Ltd
  • Cayman Chemicals
  • Martek Bioscience
  • Guangdong Runke
  • Royal DSM
  • A & Z Food Additives Co., Ltd
  • Zhejiang Weiss (Wecan)
  • BASF
Note: Product cover images may vary from those shown